Article in Organic letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors.
Xuedan WuBiomedical Research Imaging Center, Department of Radiology, and UNC Lineberger Comprehensive Cancer Center, University of North Carolina-Chapel Hill, 125 Mason Farm Road, Marsico Hall, Chapel Hill, North Carolina 27599, United States.ORCID 0000-0001-5875-4233
Wei ChenBiomedical Research Imaging Center, Department of Radiology, and UNC Lineberger Comprehensive Cancer Center, University of North Carolina-Chapel Hill, 125 Mason Farm Road, Marsico Hall, Chapel Hill, North Carolina 27599, United States.
Huaifu DengBiomedical Research Imaging Center, Department of Radiology, and UNC Lineberger Comprehensive Cancer Center, University of North Carolina-Chapel Hill, 125 Mason Farm Road, Marsico Hall, Chapel Hill, North Carolina 27599, United States.
Li WangBiomedical Research Imaging Center, Department of Radiology, and UNC Lineberger Comprehensive Cancer Center, University of North Carolina-Chapel Hill, 125 Mason Farm Road, Marsico Hall, Chapel Hill, North Carolina 27599, United States.ORCID 0000-0003-0284-5958
David A NicewiczDepartment of Chemistry, University of North Carolina-Chapel Hill, 125 South Road, Chapel Hill, North Carolina 27514, United States.ORCID 0000-0003-1199-9879
Zibo LiBiomedical Research Imaging Center, Department of Radiology, and UNC Lineberger Comprehensive Cancer Center, University of North Carolina-Chapel Hill, 125 Mason Farm Road, Marsico Hall, Chapel Hill, North Carolina 27599, United States.ORCID 0000-0002-1063-0298
Zhanhong WuBiomedical Research Imaging Center, Department of Radiology, and UNC Lineberger Comprehensive Cancer Center, University of North Carolina-Chapel Hill, 125 Mason Farm Road, Marsico Hall, Chapel Hill, North Carolina 27599, United States.
Funding
Novel Catalytic Methods for Efficient Radiolabeling of Un-activated Arene Compounds SupplementR01EB029451 · NIBIB · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LI, ZIBO, NICEWICZ, DAVID A · 2020 to 2023
$2.2M
The development of novel PET/NIRF agents for hyperparathyroidism managementR01DK128447 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KIM, LAWRENCE THOMAS, WU, ZHANHONG · 2021 to 2024
$2.0M
Development of IDO PET agents for immunotherapyR01CA233904 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LI, ZIBO, MOSCHOS, STERGIOS · 2019 to 2023
$2.0M
Small Animal PET/CT for Preclinical Imaging ResearchS10OD023611 · OD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LI, ZIBO · 2017 to 2017
$835k
Development of LED Photoredox Radiolabeling DeviceR43EB033720 · NIBIB · LED RADIOFLUIDICS CORP · PI WU, XUEDAN · 2022 to 2022
In this study, we introduce a practical methodology for the synthesis of PET probes by seamlessly combining flow chemistry with photoredox radiofluorination. The clinical PET tracer 6-[
Indexed as
Fluorine RadioisotopesPositron-Emission TomographyDihydroxyphenylalanineHalogenationMolecular StructureOxidation-ReductionPhotochemical ProcessesRadiopharmaceuticalsDihydroxyphenylalanineFluorine Radioisotopesfluorodopa F 18Radiopharmaceuticals
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.